In our recent work18, we reported reduced expression of SIRT1 (Sirtuin 1) and RGS2 (regulator of G-protein signaling 2) in lymphoblastoid cell lines (LCLs) from AD patients compared with healthy controls. This evidence concerns the gene RGS2 and Alzheimer disease.